Sweeping Opioid Legislation Passed Without Restrictions on Kratom
Thanks to the tireless work of grassroots advocates, lobbyists, and citizens from around the country, a last minute attempt to include the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act was not included in Congress’ final opioid bill H.R. 6, protecting Kratom from federal legislation — for now. However, Kratom is still under the constant threat of regulatory restrictions by the Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) as well as state legislatures and local municipalities.